Ruvinov Emil, Tavor Re'em Tali, Witte Frank, Cohen Smadar
Avram and Stella Goldstein-Goren Department of Biotechnology Engineering, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Julius Wolff Institute and Center for Musculoskeletal Surgery, Berlin-Brandenburg Center for Regenerative Therapies, Charité - Universitätsmedizin Berlin, Berlin, Germany.
J Orthop Translat. 2018 Sep 9;16:40-52. doi: 10.1016/j.jot.2018.08.003. eCollection 2019 Jan.
Despite intensive research, regeneration of articular cartilage largely remains an unresolved medical concern as the clinically available modalities still suffer from long-term inconsistent data, relatively high failure rates and high prices of more promising approaches, such as cell therapy. In the present study, we aimed to evaluate the feasibility and long-term efficacy of a bilayered injectable acellular affinity-binding alginate hydrogel in a large animal model of osteochondral defects.
The affinity-binding alginate hydrogel is designed for presentation and slow release of chondrogenic and osteogenic inducers (transforming growth factor-β1 and bone morphogenic protein 4, respectively) in two distinct and separate hydrogel layers. The hydrogel was injected into the osteochondral defects created in the femoral medial condyle in mini-pigs, and various outcomes were evaluated after 6 months.
Macroscopical and histological assessment of the defects treated with growth factor affinity-bound hydrogel showed effective reconstruction of articular cartilage layer, with major features of hyaline tissue, such as a glossy surface and cellular organisation, associated with marked deposition of proteoglycans and type II collagen. Microcomputed tomography showed incomplete bone formation in both treatment groups, which was nevertheless augmented by the presence of affinity-bound growth factors. Importantly, the physical nature of the applied hydrogel ensured its shear resistance, seamless integration and topographical matching to the surroundings and opposing articulating surface.
The treatment with acellular injectable growth factor-loaded affinity-binding alginate hydrogel resulted in effective tissue restoration with major hallmarks of hyaline cartilage, shown in large animal model after 6-month follow-up.
This proof-of-concept study in a clinically relevant large animal model showed promising potential of an injectable acellular growth factor-loaded affinity-binding alginate hydrogel for effective repair and regeneration of articular hyaline cartilage, representing a strong candidate for future clinical development.
尽管进行了深入研究,但关节软骨再生在很大程度上仍是一个尚未解决的医学问题,因为目前临床上可用的方法仍然存在长期数据不一致、失败率相对较高以及更有前景的方法(如细胞疗法)价格高昂等问题。在本研究中,我们旨在评估双层可注射脱细胞亲和结合海藻酸盐水凝胶在大型动物骨软骨缺损模型中的可行性和长期疗效。
亲和结合海藻酸盐水凝胶设计用于在两个不同且分开的水凝胶层中呈现和缓慢释放软骨生成诱导剂和成骨诱导剂(分别为转化生长因子-β1和骨形态发生蛋白4)。将该水凝胶注射到小型猪股骨内侧髁创建的骨软骨缺损中,并在6个月后评估各种结果。
对用生长因子亲和结合水凝胶治疗的缺损进行宏观和组织学评估显示,关节软骨层有效重建,具有透明组织的主要特征,如表面光滑和细胞组织,伴有蛋白聚糖和II型胶原的显著沉积。微型计算机断层扫描显示两个治疗组的骨形成均不完全,不过亲和结合生长因子的存在增强了骨形成。重要的是,所应用水凝胶的物理性质确保了其抗剪切性、与周围环境和相对关节表面的无缝整合以及地形匹配。
在大型动物模型中进行6个月随访后发现,用脱细胞可注射负载生长因子的亲和结合海藻酸盐水凝胶治疗可有效恢复组织,具有透明软骨的主要特征。
这项在临床相关大型动物模型中的概念验证研究表明,可注射脱细胞负载生长因子的亲和结合海藻酸盐水凝胶在有效修复和再生关节透明软骨方面具有广阔前景,是未来临床开发的有力候选者。